vs
C4 Therapeutics, Inc.（CCCC）与泛美白银（USAS）财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是C4 Therapeutics, Inc.的1.7倍（$19.1M vs $11.0M），泛美白银净利率更高（-82.3% vs -186.0%，领先103.6%），C4 Therapeutics, Inc.同比增速更快（112.8% vs -28.0%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
泛美白银是一家总部位于加拿大的矿业企业，业务布局集中在拉丁美洲，在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目，是美洲地区重要的贵金属开采企业。
CCCC vs USAS — 直观对比
营收规模更大
USAS
是对方的1.7倍
$11.0M
营收增速更快
CCCC
高出140.8%
-28.0%
净利率更高
USAS
高出103.6%
-186.0%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $19.1M |
| 净利润 | $-20.5M | $-15.7M |
| 毛利率 | — | 34.2% |
| 营业利润率 | -210.1% | — |
| 净利率 | -186.0% | -82.3% |
| 营收同比 | 112.8% | -28.0% |
| 净利润同比 | 40.7% | 2.8% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCUSAS
| Q4 25 | $11.0M | — | ||
| Q3 25 | $11.2M | $19.1M | ||
| Q2 25 | $6.5M | — | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $15.4M | $26.5M | ||
| Q2 24 | $12.0M | — | ||
| Q1 24 | $3.0M | — |
净利润CCCCUSAS
| Q4 25 | $-20.5M | — | ||
| Q3 25 | $-32.2M | $-15.7M | ||
| Q2 25 | $-26.0M | — | ||
| Q1 25 | $-26.3M | — | ||
| Q4 24 | $-34.6M | — | ||
| Q3 24 | $-24.7M | $-16.2M | ||
| Q2 24 | $-17.7M | — | ||
| Q1 24 | $-28.4M | — |
毛利率CCCCUSAS
| Q4 25 | — | — | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CCCCUSAS
| Q4 25 | -210.1% | — | ||
| Q3 25 | -306.4% | — | ||
| Q2 25 | -441.0% | — | ||
| Q1 25 | -402.9% | — | ||
| Q4 24 | -728.4% | — | ||
| Q3 24 | -183.9% | — | ||
| Q2 24 | -178.6% | — | ||
| Q1 24 | -1060.2% | — |
净利率CCCCUSAS
| Q4 25 | -186.0% | — | ||
| Q3 25 | -286.4% | -82.3% | ||
| Q2 25 | -402.6% | — | ||
| Q1 25 | -363.7% | — | ||
| Q4 24 | -667.8% | — | ||
| Q3 24 | -160.6% | -60.9% | ||
| Q2 24 | -147.6% | — | ||
| Q1 24 | -933.2% | — |
每股收益（稀释后）CCCCUSAS
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.44 | — | ||
| Q2 25 | $-0.37 | — | ||
| Q1 25 | $-0.37 | — | ||
| Q4 24 | $-0.50 | — | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.41 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $256.6M | $50.2M |
| 总资产 | $359.1M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCCCUSAS
| Q4 25 | $74.6M | — | ||
| Q3 25 | $58.8M | $39.1M | ||
| Q2 25 | $78.2M | — | ||
| Q1 25 | $51.3M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $59.6M | — | ||
| Q2 24 | $73.1M | — | ||
| Q1 24 | $89.7M | — |
股东权益CCCCUSAS
| Q4 25 | $256.6M | — | ||
| Q3 25 | $154.4M | $50.2M | ||
| Q2 25 | $174.1M | — | ||
| Q1 25 | $195.1M | — | ||
| Q4 24 | $216.0M | — | ||
| Q3 24 | $242.7M | $53.1M | ||
| Q2 24 | $247.1M | — | ||
| Q1 24 | $258.3M | — |
总资产CCCCUSAS
| Q4 25 | $359.1M | — | ||
| Q3 25 | $265.5M | $234.7M | ||
| Q2 25 | $296.5M | — | ||
| Q1 25 | $319.5M | — | ||
| Q4 24 | $349.6M | — | ||
| Q3 24 | $376.1M | — | ||
| Q2 24 | $381.1M | — | ||
| Q1 24 | $398.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-41.3M |
| 自由现金流率自由现金流/营收 | — | -216.5% |
| 资本支出强度资本支出/营收 | — | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CCCCUSAS
| Q4 25 | $-22.1M | — | ||
| Q3 25 | $-31.2M | $-12.5M | ||
| Q2 25 | $-12.1M | — | ||
| Q1 25 | $-33.3M | — | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | $2.4M | ||
| Q2 24 | $-5.0M | — | ||
| Q1 24 | $-18.1M | — |
自由现金流CCCCUSAS
| Q4 25 | — | — | ||
| Q3 25 | $-31.6M | $-41.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | $-11.2M | ||
| Q2 24 | $-5.2M | — | ||
| Q1 24 | — | — |
自由现金流率CCCCUSAS
| Q4 25 | — | — | ||
| Q3 25 | -281.5% | -216.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -346.5% | — | ||
| Q3 24 | -157.2% | -42.2% | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | — | — |
资本支出强度CCCCUSAS
| Q4 25 | — | — | ||
| Q3 25 | 3.7% | 150.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | 51.2% | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.0% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
